Study of SP-3164 in Relapsed or Refractory Non-Hodgkin's Lymphoma
Clinical trial NCT05979857 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05979857
- Sponsor
- Salarius Pharmaceuticals, LLC
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-15
- Primary completion
- 2025-08-15
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.